Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab + SBRT in Advanced HCC
NCT04547452Phase 2Unknown
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2020
- Primary completion
- Jul 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in hepatocellular carcinoma (HCC), sponsored by West China Hospital of Sichuan University. Status: unknown.
02
Drugs
sintilimab
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT04547452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04547452.